Amyotrophic Lateral Sclerosis Clinical Trials in Dallas, Texas

4 studies are recruiting for amyotrophic lateral sclerosis in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

    The goal of this clinical trial is to learn if the drug pridopidine works to treat amyotrophic lateral sclerosis in adults. It will also help to learn about the safety of pridopidine. The main question it aims to answer is: Does pridopidine slow disease progression of ALS? Researchers will compare …

    Stage
    Phase 3
    Ages
    18 to 80
    Site
    Texas Neurology, Dallas, Texas
    Locations
    55 in total
    Run by
    Prilenia
  2. ASSESS ALL ALS Study

    The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS gene carriers and control cohorts. This consortium is being funded by the National Institutes of Heal…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Texas Neurology, Dallas, Texas
    Locations
    37 in total
    Run by
    St. Joseph's Hospital and Medical Center, Phoenix
  3. PREVENT ALL ALS Study

    The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS gene carriers and control cohorts. This consortium is begin funded by the National Institutes of Heal…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Texas Neurology, Dallas, Texas
    Locations
    32 in total
    Run by
    St. Joseph's Hospital and Medical Center, Phoenix
  4. VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration

    The VOICE Study is an early feasibility study to evaluate the initial clinical safety and efficacy of the N1 and R1 Systems device design concept in providing an ability to communicate. The Neuralink N1 Implant is intended to provide the ability to communicate to individuals with severe and irrever…

    Stage
    Not phased
    Ages
    22 to 75
    Site
    The University of Texas Southwestern Medical Center, Dallas, Texas
    Run by
    Neuralink Corp

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.